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Background: Imidazo[1,2-a]pyridines and pyrimidines are important organic fluorophores which have been
investigated as biomarkers and photochemical sensors. The effect on the luminescent property by substituents in
the heterocycle and phenyl rings, have been studied as well. In this investigation, series of 3-hydroxymethyl
imidazo[1,2-a]pyridines and pyrimidines were synthesized and evaluated in relation to fluorescence emission, based
upon the hypothesis that the hydroxymethyl group may act as an enhancer of fluorescence intensity.
Results: Compounds of both series emitted light in organic solvents dilutions as well as in acidic and alkaline
media. Quantitative fluorescence spectroscopy determined that both fused heterocycles fluoresced more intensely
than the parent unsubstituted imidazo[1,2-a]azine fluorophore. In particular, 3-hydroxymethyl imidazo[1,2-a]
pyridines fluoresced more intensely than 3-hydroxymethyl imidazo[1,2-a]pyrimidines, the latter emitting blue light
at longer wavelengths, whereas the former emitted purple light.
Conclusion: It was concluded that in most cases the hydroxymethyl moiety did act as an enhancer of the
fluorescence intensity, however, a comparison made with the fluorescence emitted by 2-aryl imidazo[1,2-a]azines
revealed that in some cases the hydroxymethyl substituent decreased the fluorescence intensity.Background
In the past few years a growing interest in the chemistry of
imidazo[1,2-a]pyrimidines and pyridines has been devel-
oped due to the extent of their applications in pharmaco-
logical science. Indeed they are known for their anxiolytic
[1], cardiovascular [2], analgesic [3,4], antihypertensive [4]
and neuroleptic [5,6] among other activities [7-9]. How-
ever, imidazo[1,2-a]pyridines and pyrimidines are also at-
tractive due to their physicochemical properties exhibited,
namely the fluorescent activity. Several studies concerning
the effects of substituents on the fluorescent properties of
imidazo[1,2-a]pyridines have been carried out, for instance,
2-phenyl (or 2-(2-naphthyl)) and/or 7-methyl substitution
caused no deterioration of the fluorescent property. The
amino or dimethylamino substitution at the 4'-position of
2-phenyl imidazo[1,2-a]pyridine shifted the fluorescence to
the visible region in polar solvents [10]. From a comparative
spectroscopy study performed on several imidazo[1,2-a]* Correspondence: hsalgado47@hotmail.com
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distribution, and reproduction in any mediumpyridines and pyrimidines, it was observed that substitution
of a proton for methyl, carboxyl, or amino group increased
the fluorescence intensity. Fluorescence was destroyed
when a ring position carried a nitro group or when the pyri-
dine or pyrimidine ring is catalytically reduced to the
5,6,7,8-tetrahydro derivative [11]. In the latter study, it was
also observed that imidazo[1,2-a]pyrimidines fluoresced
more intensely and ca. 60 nm higher than the analogous
pyridines. Taking advantage of the fluorescence property, a
imidazo1,2-a]pyridine derivative was used as a biomarker of
hypoxic tumor cells [12]. A (4-piperidinylfluorophenyl) imi-
dazo1,2-a]pyridine was applied to a multiple fluorescent
chemosensor [13]. Recently, an imidazopyrimidine based
compound was used in an electron transport layer of an
organic light emission device [14].
However, a great disadvantage of many current fluoro-
phores is their very short time of life and susceptibility
to physicochemical environments [14], therefore interest
in the development of more efficient fluorophores is
growing. In this study, the hydroxymethyl group was
investigated as an enhancer of the fluorescence property
of derivatives of imidazo[1,2-a]pyridines and imidazoistry Central Ltd. This is an Open Access article distributed under the terms of
ttp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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phores with potential use as biomarkers.
Results and discussion
The hydroxymethyl group has proved to be a promoter of
fluorescence in naphthyl thioureas [15]. In another study, it
was reported that 2-(3,4,5,6-tetrafluoro-2-hydroxyphenyl)
imidazo[1,2-a]pyridine emitted long wavelength light
around 540 nm both in polar and in nonpolar solvents
[16]. Based upon this information, it was hypothesized
that introduction of a hydroxymethyl group at position 3
of the imidazo[1,2-a]azines should enhance fluorescence
(probably through a spatial non-covalent interaction of
the hydroxyl non-bonding electrons with the aryl rings)
as compared to the parent fluorophore (the unsubstituted
imidazo[1,2-a]azine).
The two series of compounds were prepared straight-
forward (Scheme 1). Condensation of 2-amino pyridine
or 2-amino pyrimidine with the appropriately substi-
tuted 2-bromo acetophenone afforded the imidazo[1,2-a]
azine nucleus. A Vilsmeier Haack treatment on the fused
heterocycles 3 and 4 led to the corresponding 3-formyl
substituted derivatives 5. Reduction of the formyl moiety
with NaBH4 in alkaline ethyl alcohol delivered the
3-hydroxymethyl derivatives 6 and 7.
Some of these products are already known but have
not been studied in relation to a fluorescence prop-
erty. Products were fully identified by spectroscopicX N
NH2
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Scheme 1 Synthesis of 3-hydroxymethyl imidazo[1,2-a]azines and strmethods and were obtained in moderate to good
yields as shown in Tables 1 and 2. New compounds
were submitted to combustion analysis for complete
characterization.
A series of qualitative assays aimed to evaluate the
stability of the products and permanence of the
fluorescent property followed: Compound 6 g did not
fluoresce. Dilutions of the compounds (0.05 g) in
common organic solvents (10 mL) such as ethyl alco-
hol, acetone, ethyl acetate, acetonitrile and dichloro-
methane showed fluorescence, this being considerably
intense in ethyl acetate and dichloromethane. Solu-
tions of 3-hydroxymethyl imidazo[1,2-a]pyridine 6
and pyrimidine 7 derivatives at various concentra-
tions of aqueous HCl (0.1, 1 and 8 N) preserved the
fluorescence, however, this was suppressed with 10 N
HCl for the case of imidazo[1,2-a]pyrimidines 7 and
deteriorated for the case of 6 at both λ 250 and
365 nm. Addition of weakly acidic materials also pre-
served fluorescence. Thus, heterogeneous 5% aqueous
NH4Cl mixtures of 3-hydroxymethyl 6d showed a
decreased fluorescence but 7d preserved it. A pow-
dered mixture of silica gel (0.5 g), for column chro-
matography thoroughly mixed with the alcohol
derivative 7d (10 mg) fluoresced only at the long
wavelength λ 365 nm whereas 6d (10 mg) fluoresced
at both wavelengths. These results indicate that the
protonated species 8 holds the fluorescence activityAr
6 X = CH; 7 X = N



























uctures 1, 2 and 8.
Table 1 Yields and melting points of 2-aryl-3-
hydroxymethyl imidazo[1,2-a]pyridines 6




a C6H5 70% 202 - 203 >212
b 4’Cl-C6H4 61.3% 229 - 230 >240
c 4’F-C6H4 70.3% 154 - 155 153 - 155
d 4’CH3-C6H4 76.7% 274 - 275 >290
e 4’CH3O-C6H4 66.7% 166 - 167 165 - 167
f 3’,4’di-CH3O-C6H3 71% 171 - 172 170 - 172
g 4’NO2-C6H4 70% 225 - 226 224 – 226
* Reference [17].
Table 3 Spectroscopic data for 2-aryl-3-hydroxymethyl
imidazo[1,2-a]pyridines 6
UV / Vis Fluorescence







1 — 318 320 376 101.9
6a C6H5 320 320 381.6 346.91
6b 4’Cl-C6H4 323 320 381 147.17
6c 4’F-C6H4 320 320 380.4 340.42
6d 4’CH3-C6H4 323 320 381.2 306.31
6e 4’CH3O-C6H4 323 320 383.6 884.37
6f 3’,4’di-CH3O-C6H3 323 320 385.6 878.18
6g 4’NO2-C6H4 347 347 - -
*I Fluorescence intensities were standardized to a Raman blank methanol
solution.
Table 4 Spectroscopic data for 2-aryl-3-hydroxymethyl
imidazo[1,2-a]pyrimidines 7
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in solutions 0.1, 1 and 10 N NaOH gradually dimin-
ished but prevailed at both wavelenghts. Biological
materials such as egg yolk, pig blood, albumina and
Giardia lamblia cultures were fluorescent upon
addition of the imidazo[1,2-a]azines. The fluorescence
of these products remained after several days.
The quantitative fluorescence analysis performed on
one hundred-fold dilutions of the compounds showed
that imidazo[1,2-a]pyridines absorbed and emitted en-
ergy at long wavelengths (Table 3) while imidazo[1,2-a]
pyrimidines absorbed at lower wavelengths but emitted
light at longer wavelengths (Table 4).
In the case of the imidazo[1,2-a]pyridines 6, all com-
pounds fluoresced more intensely than the parent
unsubstituted imidazo[1,2-a]pyridine 1, with the excep-
tion of the nitro substituted 6 g, which showed no fluor-
escence as was expected. It is also worth noting that the
2-(4-chlorophenyl) substituted imidazopyridine deriva-
tive 6b showed a rather low intensity.
As for the case of the imidazo[1,2-a]pyrimidine series,
again the 2-(4’-chlorophenyl) substituted imidazopyrimi-
dine 7b showed a very low intensity. Surprisingly, the
electron donor substituted 7d and 7e and the nitro sub-
stituted derivative 7 g registered a similar intensity close
to that given by the parent fluorophore 2.Table 2 Yields and melting points of 2-aryl-3-
hydroxymethyl imidazo[1,2-a]pyrimidines 7
Compound 7 Aryl Yield (%) Mp (°C)
a C6H5 60.6% 241 – 242*
b 4’Cl-C6H4 63.8% 164 - 165
c 4’F-C6H4 30.3% 232 - 233
d 4’CH3-C6H4 32% 199 - 200
e 4’CH3O-C6H4 86% 187 - 188
f 3’,4’di-CH3O-C6H3 30.4% 200 - 201
g 4’NO2-C6H4 72% 213 - 214
*Compound 2a is mentioned in reference [18], mp is not given.A comparative UV absorption graph for both series of
compounds is shown in Figure 1.
Figure 2 shows a comparison of the emission inten-
sities. From these, it is clearly appreciated that imidazo
[1,2-a]pyrimidines emitted light at longer wavelengths
than analogous imidazo[1,2-a]pyridines but the latter
fluoresced more intensely, in contrast to previous
analyses on imidazo[1,2-a[azines [12]. The effects of
the phenyl substituents on the outcome of the emis-
sion intensities did not follow a consistent pattern,
some interesting results are worth pointing out. The
strong electron-donating methoxy group caused a
marked increased intensity on the imidazopyridine
(6e) but not on the imidazopyrimidine (7e). The
fluorescence intensity of the imidazo[1,2-a]azines
with the phenyl carrying the electron-withdrawing
chlorine was low in 6b and dramatically decreased in
7b, whereas the intensity of the derivative with the
phenyl bearing the fluorine substituent, 7c wasUV / Vis Fluorescence







2 — 229 230 414.8 205.58
7a C6H5 247 247 437.6 432.44
7b 4’Cl-C6H4 228 228 439.2 53.56
7c 4’F-C6H4 240 240 437.2 542.19
7d 4’CH3-C6H4 240 240 433.6 184.23
7e 4’CH3O-C6H4 226 226 433.6 188.03
7f 3’,4’di-CH3O-C6H3 344 344 432.4 428.32
7g 4’NO2-C6H4 265 265 432 186.43
*I Fluorescence intensities were standardized to a Raman blank methanol
solution.
Figure 1 UV-Visible absorption spectra of imidazo[1,2-a]azines 6 and 7.
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dazopyrimidine series. Interestingly in the case of the
4’-nitrophenyl substituted imidazo[1,2-a]pyridine, fluores-
cence was completely absent, while in the 4’-nitrophenyl
substituted imidazo[1,2-a]pyrimidine fluorescence did not
vanish.
According to the previous results, the role of the
hydroxymethyl moiety was not quite clear, therefore we
decided to revise the influence of the aryl group on the
luminescent response of the 2-aryl imidazo[1,2-a]azines.
Results for the 2-aryl imidazo[1,2-a]pyridines 3 (Table 5)
showed that the phenyl, as well as the 4’-chloro, 4’-
fluoro and 4’-methoxy substituted phenyl increased
the fluorescence intensity as compared to 1 and
interestingly the 3,4-dimethoxyphenyl caused a drop-off of the intensity. In most cases, the hydroxymethyl
group increased fluorescence intensity even more
than the aryl substituent, therefore it acted as enhancer.
However, the intensity was decreased in the 4’-fluoro sub-
stituted phenyl and even more in the case of the 4’-chloro
substituted phenyl.
As for the case of imdazopyrimidines (Table 6), sub-
stitution by phenyl did increase the intensity as com-
pared to the parent fluorophore 2, the 4’-nitro
substituted phenyl did not show fluorescence and it
was interesting to observe that the 4’-methoxy phenyl
(4f ) showed a very low intensity. With this informa-
tion, it was concluded that the hydroxymethyl moiety
was a promoter of fluorescence in compound (4 g)
and acted as an enhancer of the intensity in all other
























Figure 2 A comparison of emission wavelengths and intensity of imidazo[1,2-a]azines 6 and 7.
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pyrimidine where a decrement was found. Figure 3
shows a comparative graph of the emission wave-
lengths and fluorescence obtained for compounds 3
and 4.
Thermal properties
The thermal stability of the most fluorescent compounds,
6a, 6e, 6f, 7a, 7c and 7f was estimated through a thermo
gravimetric analysis (TGA) within an interval 0 – 600°C
under an inert atmosphere. From the TG curves shown in
Figure 4 it was determined that these compounds were
thermally stable up to 280°C. The thermodynamic most
stable was 7f, which completely decomposed above 600°CTable 5 Fluorescence data for 2-aryl imidazo[1,2-a]
pyridines 3
R UV / Vis Fluorescence







1 — 318 320 376.0 101-9
3a C6H5 237 240 375.6 367.8
3b 4’Cl-C6H4 245 245 375.2 310.92
3c 4’F-C6H4 300 300 374 470.34
3e 4’MeO-C6H4 315 315 381.6 407.83
3f 3’,4’diMeO- C6H3 228 230 385.6 178.19
*I Fluorescence intensities were standardized to a Raman blank methanol
solution.(47.75% mass loss at 600°C). The chemically most stable
was 6f (55.25% weight loss at 600°C) and compound 7a
showed a 66.47% weight loss at 600°C, the least stable was
6a (95.25% weight loss at 600°C).
Experimental
Melting points were measured on an Electrothermal
melting point apparatus and are uncorrected. The FT-IR
spectra were recorded on Perkins-Elmer 257 spectrom-
eter using KBr discs. 1 H and 13C nmr spectral data were
recorded with a Varian Mercury 300 MHz or a Varian
500 spectrometer. The chemical shifts (δ) are referenced
to internal (CH3)4Si (δ
1 H = 0, δ 13C = 0). FluorescenceTable 6 Fluorescence data for 2-aryl imidazo[1,2-a]
pyrimidines 4
UV / Vis Fluorescence







2 — 229 230 414.8 205.58
4a C6H5 237 240 429.2 351.98
4b 4’Cl-C6H4 245 245 428.4 334.1
4c 4’F-C6H4 240 240 431.6 355.16
4e 4’MeO-C6H4 240 240 439.2 303.01
4f 3’,4’diMeO-C6H3 222 222 447.6 55.998
4g 4’NO2-C6H4 352 352 — —
*I Fluorescence intensities were standardized to a Raman blank methanol
solution.





















Figure 3 A comparison of emission wavelengths and fluorescence intensity for imidazo[1,2-a]pyridines 3 and imidazo[1,2-a]
pyrimidines 4.
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http://journal.chemistrycentral.com/content/6/1/83measurements were performed with a Shimadzu
spectrofluorophotometer (RF-5000), equipped with a
150-W Xenon lamp, 12” color video display, 1 x
1 cm quartz cells. Both, operational performance and
instrument sensitivity were revised by running a
Raman spectrum of methanol. Cells were mounted in
the holding device. The cell was filled out with aFigure 4 Thermogravimetric analysis of selected 3-hydroxymethyl imdilution 1:100 of the compounds in question for vari-
ous lengths and then washed four times with metha-
nol. Thermo gravimetric analysis was performed on a
TGA 2950 Thermogravimetric Analyzer TA Instru-
ments in a range 0-600°C, at a rate of 10°C/min on a
platinum tray, under a nitrogen atmosphere and a
flux rate 37.5 and 25.idazo[1,2-a]pyridine and pyrimidine derivatives.
Velázquez-Olvera et al. Chemistry Central Journal 2012, 6:83 Page 7 of 9
http://journal.chemistrycentral.com/content/6/1/83General procedure for the synthesis of 3-hydroxymethyl
imidazo[1,2-a]pyridines and pyrimidines
In a round bottom flask equipped with a magnetic stirrer,
1 g of the formyl derivative was suspended in ethanol
(30 mL). The mixture was heated to 30°C and NaBH4 dis-
solved in 2 mL of 0.1 N NaOH added (2 molar equivalents
for imidazo[1,2-a]pyridine and 1 molar equivalent for imi-
dazo[1,2-a]pyrimidine). The reaction mixture was left stir-
ring and reaction progress monitored by thin layer
chromatography. After completion, ethanol was removed
under vacuum. The solid formed was re-suspended in
water and concentrated HCl added dropwise to neutral
pH. The solid was collected by filtration, washed with
water and dried off with hexane.
2-Phenyl-3-hydroxymethy imidazo[1,2-a]pyridine 6a
IR υ max cm-1: 3290 (OH); 2966.57, 2916.51, 2848.34
(C-H); 1734.11 (C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.46 (1H, dd, J5,6=6.9,
J5,7=1.2, H5); 7.84 (2H, d, J2’,3’=6.9, H2’,6’); 7.61 (1H, dd,
J8,7=8.1, J8,6=1.2, H8); 7.48 (2H, td, J3’,2’=6.9, J3’,4’=7.2,
J3’,5’=1.6 H3’,H5’); 7.38 (1H, td, J4’,3’=7.2, J4’,2’=1.6 H4’); 7.3
(1H, td, J7,8=8.1, J7,6=6.9, J7,5=1.2, H7); 6.98 (1H, td, J6,5=6.9,
J6,7=6.9, J6,8=1.2, H6); 5.44 (1H, s, OH); 4.92 (2H, s, CH2).
13C NMR (75.5MHz, DMSO-d6) δ: 143.9 (C5), 142.8
(C8a); 134.3 (C1’), 128.4 (C2’); 128.1 (C3’); 128.2 (C4’);
124.8 (C7); 120.4 (C3); 116.6 (C8); 111.9 (C6); 52.8 (CH2).
2-(4’-Chlorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6b
Isolated as a white solid in 61.3% yield, mp 229 - 230ºC
(Lit 15, mp >240°C).
IR υ max cm-1: 3398 (OH); 2930 (C-H); 1635 (C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.46 (1H, d, J5,6=6.9,
H5); 7.87 (2H, d, J2’,3’=8.8, H2’); 7.6 (1H, d, J8,7=9.0, H8); 7.52
(2H, d, J3’,2’=8.8, H3’,5’); 7.31 (1H, td, J7,8=9.0, J7,6=6.8,
J7,5=1.2, H7); 6.98 (1H, td, J6,5=6.9, J6,7=6.8, J6,8=1.2, H6);
5.47 (1H, t, J=4.8, OH); 4.92 (2H, d, J=4.8, CH2).
13C NMR (125MHz, DMSO-d6) δ: 143.9 (C5); 142.8
(C8a); 134.3 (C1’); 128.4 (C2’); 128.1 (C3’); 128.2 (C4’);
125.0 (C2); 124.8 (C7); 120.4 (C3); 116.6 (C8); 111.9 (C6);
52.8 (CH2).
2-(4’-Fluorophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6c
Isolated as a white solid in 70.3% yield, mp 154 - 155ºC
(Lit 15, mp 153 - 155°C).
IR υ max cm-1: 3427 (OH); 3137 and 3048 (C-H); 1600
(C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.52 (1H, d, J5,6=6.9,
H5); 8.0 (2H, dd, J2’,3’=9.0, Jm=5.7, H2’ and H6’); 7.57 (1H, d,
J8,7=9.3, H8); 7.37 – 7.29 (3H, m, H7,3’,5’); 6.87 (1H, d,
J6,5=6.9, H6); 5.54 (1H, s, OH); 4.91 (2H, s, CH2).
13C NMR (125MHz, DMSO-d6) δ: 163.4 and 161.0 (C4);
143.91 (C8a); 130.9 and 130.8 (C2); 125.1 (C1); 120.4 (C3);
116.6 (C8); 115.6 and 115.3 (C3); 112.1 (C6); 52.0 (CH2).2-(4’-Methylphenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine 6d
Isolated as a white solid in 76.7% yield, mp 274 - 275ºC
(Lit 15, mp >290°C).
IR υ max cm-1: 3279 (OH); 3040 y aprox 2950 (C-H);
1654 (C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.45 (1H, d, J5,6=6.9,
H5); 7.74 (2H, d, J2’,3’=9.0, H2’,6’); 7.61 (1H, d, J8,7=9.3,
H8); 7.33 – 7.28 (3H, m, H7,3’.5’); 6.98 (1H, dd, J6,5=6.9,
J6,7=6.9, H6); 5.45 (1H, t, J=5.1, OH); 4.91 (2H, d, J=5.1,
CH2); 2.36 (3H, s, CH3).
13C NMR (125MHz, DMSO-d6) δ: 143.9 (C5); 142.9
(C8a); 136.9 (C1’); 131.6 (C4’); 129.1 (C3’); 128.1 (C2’);
125.1 (C2); 124.9 (C7); 120.2 (C3); 116.5 (C8); 112.0 (C6);
52.2 (CH2); 20.8 (CH3).
2-(4’-Methoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]
pyridine 6e
Isolated as a white solid in 66.7% yield, mp 166 - 167ºC
(Lit 15, mp 165 - 167°C).
IR υ max cm-1: 3427 (OH); ca. 2950 (C-H); 1610 (C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.43 (1H, dd,
J5,6=6.9, J5,7=1.5 H5); 7.77 (2H, d, J2’,3’=9.0, H2’,6’); 7.57
(1H, d, J8,7=9.0, H8); 7.28 (1H, td, J7,8=9.0, J7,6=6.6,
J7,5=1.5, H7); 7.04 (2H, d, J3’,2’=9.0, H3’,5’); 6.95 (1H, d
J6,7=6.6, H6); 5.37 (1H, d, J=5.1, OH); 4.9 (2H, d, J=5.1,
CH2); 3.82 (3H, s, OCH3).
13C NMR (75.5MHz, DMSO-d6) δ: 157 (C4’); 141.9 (C5);
140.9 (C8a); 127.4 (C2’); 124.9 (C4); 123 (C1’); 122.7 (C2’);
117.8 (C3); 114.5 (C8); 112 (C3’); 109.8 (C6); 53.2 (CH2).
2-(3’,4’-Dimethoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]
pyridine 6f
Isolated as a brown solid in 71% yield, mp 171 - 172ºC
(Lit 15, mp 170 - 172°C).
IR υ max cm-1: 3004.19 (OH); 2933.8 and 2834.93
(C-H); 1633.76 (C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.46 (1H, d, J5,6=7.2
H5); 8.44 (1H, dd, J8,7=7.0, J8,6=1.6, H7); 7.61 (1H, d,
J2’,6’=1.2, H2’); 7.56 (1H, dd, J6’,5’=6.4, J6’,2’=1.2 H6’); 7.50
(1H, dd, J7,8=7.0, J7,5=1.6 H7); 6.9 (1H, d, J5’,6’=8.0, H5’);
6.8(1H, td, J6,5=7.2, J6,7=7.2 J6,8=1.2 H6) ; 5.4 (1H, s, OH);
4.9 (2H, s, CH2); 3.83 (3H, s, OCH3), 3.81, (3H, s,
OCH3).
13C NMR (125MHz, DMSO-d6) δ: 148.7 (C7); 148.5
(C4’); 143.7 (C3’); 142.9 (C8a); 127.03 (C2); 124.6 (C5);
120.4 (C1’); 119.8 (C6’); 116.4 (C3); 111.8 (C2’ and C5’);
111.7 (C6), 55.46 and 55.38 (OCH3); 52.1 (CH2).
2-(4’-Nitrophenyl)-3-hydroxymethyl imidazo[1,2-a]pyridine
6g
Isolated as a yellow solid in 70% yield, mp 225 - 226ºC
(Lit 15, mp 224 - 226°C).
IR υ max cm-1: 3417 (OH); 3130, 2943 (C-H); 1600
(C = C).
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8.49 (2 H, d, J2’,3’ = 8.9); 8.14 (2 H, d, J2’,3’ = 8.9); 7.62 (1 H, d,
J7,8 = 9.0); 7.34 (1 H, ddd, J5,7 = 1.2, J6,7 = 6.9, J7,8 = 9.0); 7.0
(1 H, ddd, J6,8 = 1.2, J5,6 = 6.9, J6,7 = 6.9); 5.55 (1 H, t, J = 5.1,
OH); 4.98 (2 H, d, J = 5.1, CH2).
13C NMR (125MHz, DMSO-d6) δ: 146.3 (C5); 144.2
(C8a); 140.8 (C1); 140.3 (C3); 128.6 (C3’); 125.4 (C4’);
125.0 (C2); 123.4 (C2’); 122.2 (C7); 116.8 (C8); 112.3 (C6);
52.0 (CH2).
2-Phenyl-3-hydroxymethyl imidazo[1,2-a]pyrimidine 7a
Isolated as a yellow solid in 60.6% yield, mp 241 - 242ºC.
IR υ max cm-1: 3216 (OH); 3082, 2948 y 2884 (C-H);
1614 (C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.92 (1H, dd, J5,6=6.9,
J5,7=1.2, H5); 7.84 (2H, d, J2’,3’=6.9, H2’,6’); 7.61 (1H, dd,
J7,6=8.1, J7,5=1.2, H7); 7.53 (2H, dd, J3’,2’=6.9, J3’,4’=7.2, H3’,5’);
7.4 (1H, dd, J4’,3’=7.2, H4’); 7.1 (1H, td, J6,5=6.9, J6,7=6.9,
J6,8=1.2, H6); 5.45 (1H, s, OH); 4.96 (2H, s, CH2).
13C NMR (75.5MHz, DMSO-d6) δ: 150.5 (C5), 147.2
(C8a); 143.6 (C1’), 133.8 (C2’); 128.6 (C3’); 128.3 (C4’); 128
(C7); 119.2 (C3); 108.6 (C8); 111.9 (C6); 51.8 (CH2).
Anal. calcd for C13H11N3O: C, 69.33 H, 4.88, N, 18.76;
found: C, 69.41, H, 5.2, N, 18.46.
2-(4’-Chlorophenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7b
Isolated as a yellow solid in 63.8% yield, mp 164 - 165ºC.
IR υ max cm-1: 3400 - 1900 (OH and C-H); 1662 and
1618 (C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.97 (1H, d, J5,6=7.0,
H5); 8.61 (1H, dd, J7,6=4.0, J7,5=2.0, H7); 7.91 (2H, d,
J2’,3’=8.5, H2’,6’); 7.58 (2H, dd, J3’,2’=8.5, H3’,5’); 7.15 (1H, dd,
J6,5=7.0, J6,7= 4.0, H6); 5.65 (1H, s, OH); 4.92 (2H, s, CH2).
13C- NMR (125MHz, DMSO-d6) δ: 150.6 (C7); 147.2
(C8a); 142.2 (C2); 133.6 (C5); 132.8 (C1’); 132.6 (C4’); 129.9
(C2’); 128.7 (C3’); 119.4 (C6); 108.7 (C3); 56.0 (CH2).
Anal. calcd for C13H10N3OCl: 60.11 H, 3.85, N, 16.19;
found: C, 60.23, H, 4.01, N, 15.92.
2-(4’-Fluorophenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7c
Isolated as a yellow solid in 30.3% yield, mp 232 - 233ºC.
IR υ max cm-1: 3300 (OH); 3076 (C-H); 1659 and 1615
(C=C).
1H NMR (500MHz, DMSO-d6) δ: 9.01 (1H, dd,
J5,6=6.5, J5,7=2.0, H5); 8.59 (1H, dd, J7,6=4.0, J7,5=2.0, H7);
7.92 (2H, dd, J2’,3’=12.0, J2’F=5.0, H2’); 7.34 (2H, dd,
J2’,3’=12.0, J3’F=9.0, H3’); 7.14 (1H, dd, J6,7=4.0, J6,5=6.5
H6); 5.72 (1H, s, OH); 4.9 (2H, s, CH2).
13C NMR (125MHz, DMSO-d6) δ: 163.4 and 161.0
(C4); 150.4 (C7); 147.0 (C8a); 142.4 (C2); 133.6 (C5); 130.2
(C2’); 130.1 (C1’); 119.2 (C6); 115.6 and 115.4 (C3’); 108.6
(C3); 51.5 (CH2).Anal. calcd for C13H10N3OF: 64.19 H, 4.11, N, 17.28;
found: C, 65.26, H, 4.23, N, 16.98.
2-(4’-Methylphenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7d
Isolated as a yellow solid in 32% yield, mp 199 - 200ºC.
IR υ max cm-1: 3369 (OH); 2926 (C-H); 1617 (C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.99 (1H, dd,
J5,6=6.5, J5,7=1.5, H5); 8.59 (1H, dd, J7,6=7.0, J7,5=1.5, H7);
7.9 (2H, d, J2’,3’=8.0, H2’,6’) 7.57 (2H, d, J3’,2’=8.0, H3’,5’);
7.13 (1H, dd, J6,7=7.0, J6,5=6.5, H6); 5.7 (1H, s, OH); 4.91
(2H, s, CH2); 3.38 (3H, s, CH3).
13C NMR (125MHz, DMSO-d6) δ: 150.7 (C7); 147.1
(C8a); 142.2 (C2); 133.6 (C5); 132.7 (C1’); 132.7 (C4’);
129.8 (C3’); 128.6 (C2’); 119.6 (C6); 108.6 (C3); 55.9
(CH2); 51.5 (CH3).
Anal. calcd for C14H13N3O: 70.29 H, 5.39, N, 17.57;
found: C, 70.13, H, 5.51, N, 17.38.
2-(4’-Methoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7e
Isolated as a yellow solid in 86% yield, mp 187 - 188ºC.
IR υ max cm-1: 3409 (OH); aprox 2900 (C-H); 1617
(C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.95 (1H, dd,
J5,6=6.5, J5,7=2.0, H5); 8.56 (1H, dd, J7,6=4.0, J7,5=2.0, H7)
7.82 (2H, d, J2’,3’=8.5, H2’,6’); 7.12 (1H, dd, J6,5=6.5,
J6,7=4.0, H6); 7.08 (2H, dd, J3’,2’=8.5, H3’,5’); 5.62 (1H, s,
OH); 4.9 (2H, s, CH2); 3.83 (3H, s, OCH3).
13C NMR (125MHz, DMSO-d6) δ: 159.2 (C4’); 149.9
(C7); 147.1 (C8a); 143.6 (C2); 133.3 (C5); 129.5 (C2’); 118.4
(C6); 114.1 (C3’); 108.3 (C3); 55.2 (CH2) 51.7 (OCH3).
Anal. calcd for C14H13N3O2: 65.88 H, 5.09, N, 16.47;
found: C, 65.66, H, 4.80, N, 16.29.
2-(3’,4’-Dimethoxyphenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7f
Isolated as a brown solid in 30.4% yield, mp 200 - 201ºC.
IR υ max cm-1: 3397 (OH); 3083, 2994 and 2937 (C-H);
1615 (C=C).
1H NMR (500MHz, DMSO-d6) δ: 8.97 (1H, d, J5,6=4.0,
H5); 8.56 (1H, d, J7,6=2.0, H7); 7.49 (1H, d, J2’,6’=2.0, H2’);
7.42 (1H, d, J6’,5’=8.0, H6’); 7.09 (2H, m, H5’,6); 5.46 (1H, s,
OH); 4.93 (2H, s, CH2); 3.8 (6H, s, OCH3).
13C NMR (125MHz, DMSO-d6) δ: 149.9 (C7); 148.8
(C4’); 148.7 (C3’); 147.0 (C8a); 143.7 (C2); 133.3 (C5);
126.4 (C1’); 120.7 (C6’); 118.6 (C3); 111.8 (C2’ and C5’);
108.6 (C6), 55.5 and 55.4 (OCH3); 51.7 (CH2).
Anal. calcd for C15H15N3O3: 63.15 H, 5.26, N, 14.73;
found: C, 63.01, H, 5.17, N, 14.44.
2-(4’-Nitrophenyl)-3-hydroxymethyl imidazo[1,2-a]
pyrimidine 7g
Isolated as a yellow solid in 72% yield, mp 213 - 214ºC.
Velázquez-Olvera et al. Chemistry Central Journal 2012, 6:83 Page 9 of 9
http://journal.chemistrycentral.com/content/6/1/83IR υ max cm-1: 3376 (OH); 2933 (C-H); 1675 (C=C).
1H NMR (300MHz, DMSO-d6) δ: 8.64 (1H, t, J5,6=6.9,
J5,7=1.2, H5); 8.34 (2H, dd, J2’,3’=8.7, H3’); 8.15 (2H, d,
J2’,3’=8.7, H2’); 7.1 (1H, dd, J6,8=1.2, J7,8=9.0, H8); 6.15
(1H, dd, J5,7=1.2, J6,7=6.6, J7,8=9.0, H7); 5.59 (1H, d,
J6,8=1.2, H8); 4.9 (1H, t, J5,7=1.2, J6,7=6.6, J7,8=9.0, H7);
3.32 (1H, t, J5,6=6.9, J6,7=6.6, J6,8=1.2, H6); 2.9 (1H, d,
J=5.1, OH); 2.4 (2H, d, J=5.1, CH2).
13C NMR (125MHz, DMSO-d6) δ: 152.7 (C5); 148.6
(C8a); 148.06 (C1); 142.3 (C3); 141.6 (C3’); 135.2 (C4’);
125.0 (C2); 130.3 (C2’); 125.2 (C7); 122.6 (C8); 110.3 (C6);
52.88 (CH2).
Anal. calcd for C13H10N4O3: 57.77 H, 3.70, N, 20.74;
found: C, 57.56, H, 3.85, N, 20.62.
Conclusion
2-Aryl-3-hydroxymethyl imidazo[1,2-a]pyridines and 2-
aryl-3-hydroxymethyl imidazo[1,2-a]pyrimidines emitted
light at long wavelengths more intensely than the re-
spective non-substituted imidazo[1,2-a]pyridine and pyr-
imidine fluorophores. The hydroxymethyl group was an
enhancer of the fluorescence intensity of the 2-aryl imi-
dazo[1,2-a]azines, although in some cases it caused a
decrement of the luminescent activity. These findings in-
dicate that an interplay of the electronic character of the
phenyl substituents with the hydroxymethyl moiety is
most probably operating. The thermogravimetric ana-
lysis on selected most fluorescent imidazo[1,2-a]azines,
indicated that they are thermally stable up to 280°C.
Other studies aimed to decide if the herein investigated
compounds are suitable as effective fluorescent dyes in
biological applications are currently underway.
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